| 1 |
Mostafavi B, Forghani-ramandi M, Yaslianifard S, Alizadeh M, Dayer A, Asgari Z, Mozhgani S. Identification of genes and signaling pathways associated with severe COVID-19: high-throughput data analysis with a system virology approach.. [DOI: 10.21203/rs.3.rs-2364259/v1] [Reference Citation Analysis]
|
| 2 |
Cuicchi D, Gabrielli L, Tardio ML, Rossini G, D’Errico A, Viale P, Lazzarotto T, Poggioli G. Virological and histological evaluation of intestinal samples in COVID-19 patients. World J Gastroenterol 2022; 28(44): 6282-6293 [DOI: 10.3748/wjg.v28.i44.6282] [Reference Citation Analysis]
|
| 3 |
Pirzadeh M, Prescott HC. Impact of COVID-19 on Non-Pulmonary Critical Illness: Prevalence, Clinical Manifestations, Management, and Outcomes. Clinics in Chest Medicine 2022. [DOI: 10.1016/j.ccm.2022.11.011] [Reference Citation Analysis]
|
| 4 |
Pham N, Hu F, Evelo CT, Kutmon M. Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients. Front Immunol 2022;13:963357. [DOI: 10.3389/fimmu.2022.963357] [Reference Citation Analysis]
|
| 5 |
Abd HA, Kasim AA, Shareef LG. Serum levels of α1-antitrypsin, interleukin-1β and interleukin-6 in Iraqi COVID-19 patients: A cross-sectional study. F1000Res 2022;11:921. [DOI: 10.12688/f1000research.124473.1] [Reference Citation Analysis]
|
| 6 |
Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Chaudhry ZL, Gamal M, Ferhati I, Warda M, Ahmed BY. ER Stress in COVID-19 and Parkinson’s Disease: In Vitro and In Silico Evidences. Brain Sciences 2022;12:507. [DOI: 10.3390/brainsci12040507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Pampalone M, Vitale G, Gruttadauria S, Amico G, Iannolo G, Douradinha B, Mularoni A, Conaldi PG, Pietrosi G. Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant Enterobacterales in Decompensated Cirrhosis. Int J Mol Sci 2022;23:857. [PMID: 35055040 DOI: 10.3390/ijms23020857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
